Daily Cannabis Use Is a Barrier to Tobacco Cessation Among Tobacco Quitline Callers at 7-Month Follow-up.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
17 10 2022
Historique:
received: 15 12 2021
revised: 08 03 2022
accepted: 07 04 2022
pubmed: 14 4 2022
medline: 20 10 2022
entrez: 13 4 2022
Statut: ppublish

Résumé

Cannabis use is increasing among cigarette smokers in the United States. Prior studies suggest that cannabis use may be a barrier to smoking cessation. Yet, the extent to which this is the case among adults seeking to quit tobacco use remains unclear. Tobacco quitlines are the most common provider of no-cost treatment for adults who use smoke in the United States. This study investigated the association between cannabis use and smoking cessation outcomes among quitline callers. Participants included callers to the New York State Smokers' Quitline, who were seeking to quit smoking cigarettes and were contacted for outcome assessment 7 months after intake. Thirty-day point prevalence abstinence rates were calculated and compared among cannabis use groups, based on frequency of past-30-day cannabis use at baseline (none: 0 days, occasional: 1-9 days, regular: 10-19 days, and daily: 20-30 days). Approximately 8.3% (n = 283) of participants (n = 3396) reported past-30-day cannabis use at baseline. Callers with daily cannabis use (20-30 days per month) had significantly lower odds of 30-day abstinence, relative to those who did not use cannabis (odds ratio = 0.5; 95% confidence interval [0.3, 0.9]). Daily cannabis use appears to be associated with poorer smoking cessation treatment outcomes among adults seeking to quit smoking cigarettes via a quitline. Because quitlines are among the most accessible, affordable, and frequently utilized community-based treatments available in the United States, and the prevalence of cannabis use is increasing among cigarette smokers, detailed inquiry into cannabis use might enhance cigarette smoking cessation outcomes. Quitlines are free of cost and accessible to millions of smokers in the United States. The current study found an inverse relationship between daily cannabis use at baseline and 30-day abstinence from cigarette smoking at 7-month follow-up among New York State Smokers' Quitline callers. Findings suggest that daily cannabis use may be a barrier to smoking cessation and sustained abstinence among those seeking help to stop smoking cigarettes.

Identifiants

pubmed: 35417562
pii: 6568170
doi: 10.1093/ntr/ntac096
pmc: PMC9759104
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1684-1688

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA029926
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Tob Control. 2021 Nov 23;:
pubmed: 34815363
Addiction. 2016 Feb;111(2):375
pubmed: 26584599
Am J Drug Alcohol Abuse. 2017 Jul;43(4):416-431
pubmed: 27286288
Am J Addict. 2016 Jun;25(4):291-6
pubmed: 27187893
J Clin Psychiatry. 2018 Mar/Apr;79(2):
pubmed: 29570966
Nicotine Tob Res. 2020 Jan 27;22(1):130-134
pubmed: 30351429
JAMA. 2014 Jan 8;311(2):172-82
pubmed: 24399556
Int J Methods Psychiatr Res. 2012 Jun;21(2):88-97
pubmed: 22351472
Psychopharmacology (Berl). 2022 May;239(5):1231-1249
pubmed: 34741634
Tob Control. 2007 Dec;16 Suppl 1:i9-15
pubmed: 18048639
Nicotine Tob Res. 2020 Jul 16;22(8):1404-1408
pubmed: 31112595
Addiction. 2021 Oct;116(10):2770-2778
pubmed: 33730400
Addiction. 2021 Jul;116(7):1622-1630
pubmed: 33047862
J Stud Alcohol Drugs. 2013 Mar;74(2):301-10
pubmed: 23384378
Addiction. 2020 Oct;115(10):1800-1814
pubmed: 32003088
Aust N Z J Psychiatry. 2022 Jul;56(7):757-770
pubmed: 34708662
Curr Addict Rep. 2020 Dec;7(4):533-544
pubmed: 33777645
Curr Opin Psychol. 2021 Apr;38:80-85
pubmed: 33873044
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019
pubmed: 31725711
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
Am J Prev Med. 2020 May;58(5):691-698
pubmed: 32156490
Tob Control. 2020 Jan;29(1):74-80
pubmed: 30952691
Subst Abus. 2021;42(4):417-422
pubmed: 33270541
Drug Alcohol Depend. 2021 Jan 1;218:108364
pubmed: 33143941
Drug Alcohol Depend. 2019 Apr 1;197:134-140
pubmed: 30825793
Addiction. 2018 Apr;113(4):719-728
pubmed: 29265574
N Engl J Med. 2013 Jan 24;368(4):341-50
pubmed: 23343063
Drug Alcohol Depend. 2020 Sep 1;214:108163
pubmed: 32707516

Auteurs

Renee D Goodwin (RD)

Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Alina Shevorykin (A)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Ellen Carl (E)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Alan J Budney (AJ)

Department of Psychiatry, Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

Cheryl Rivard (C)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Melody Wu (M)

Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Erin A McClure (EA)

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Department of Psychiatry and Behavioral Sciences and Hollings Cancer Center, Technology Applications Center for Healthful Lifestyles (TACHL), South Carolina Center of Economic Excellence, Medical University of South Carolina (MUSC), Charleston, SC, USA.

Andrew Hyland (A)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Christine E Sheffer (CE)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH